Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Case report

Successful treatment of recurrent immunoglobulin a nephropathy using steroid pulse therapy plus tonsillectomy 10 years after kidney transplantation: a case presentation

Authors: Haruki Katsumata, Izumi Yamamoto, Yo Komatsuzaki, Mayuko Kawabe, Yusuke Okabayashi, Takafumi Yamakawa, Ai Katsuma, Yasuyuki Nakada, Akimitsu Kobayashi, Yudo Tanno, Jun Miki, Hiroki Yamada, Ichiro Ohkido, Nobuo Tsuboi, Hiroyasu Yamamoto, Takashi Yokoo

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Both prevention and treatment of recurrent immunoglobulin A nephropathy (IgAN) in kidney transplant recipients are important since recurrent IgAN seems to affect long-term graft survival. We present here a case of recurrent IgAN that was successfully treated using steroid pulse therapy plus tonsillectomy 10 years after kidney transplantation.

Case presentation

A 46-year-old male was admitted for an episode biopsy with a serum creatinine level of 1.8 mg/dl and proteinuria (0.7 g/day). Histological features showed recurrent IgAN (only focal segmental mesangial proliferation) and severe arteriolar hyalinosis partly associated with calcineurin inhibitor toxicity, with limited interstitial fibrosis and tubular atrophy (5%) (IF/TA) 8 years after transplantation. Sodium restriction and conversion from cyclosporine to tacrolimus successfully reduced his proteinuria to the level of 0.15 g/day. However, 2 years later, his proteinuria increased again (1.0 g/day) and a second episode biopsy showed global mesangial proliferation with glomerular endocapillary and extracapillary proliferation accompanied by progressive IF/TA (20%). The steroid pulse therapy plus tonsillectomy successfully decreased his proteinuria and he achieved clinical remission 3 years after this treatment.

Conclusion

This case, presented with a review of relevant literature, demonstrates the difficulty and importance of the treatment of recurrent IgAN and calcineurin inhibitor arteriolopathy, especially in long-term kidney allograft management.
Literature
1.
go back to reference Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2007;347:103–9.CrossRef Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2007;347:103–9.CrossRef
2.
go back to reference Moroni G, Longhi S, Quaglini S, et al. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant. 2013;28:1305–14.CrossRefPubMed Moroni G, Longhi S, Quaglini S, et al. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant. 2013;28:1305–14.CrossRefPubMed
3.
go back to reference Mulay AV, van Walraven C, Knoll GA. Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant. 2009;9:804–11.CrossRefPubMed Mulay AV, van Walraven C, Knoll GA. Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant. 2009;9:804–11.CrossRefPubMed
4.
go back to reference Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.CrossRefPubMed Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.CrossRefPubMed
5.
go back to reference Kimata N, Tanabe K, Ishikawa N, et al. Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc. 1996;28:1537–9.PubMed Kimata N, Tanabe K, Ishikawa N, et al. Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc. 1996;28:1537–9.PubMed
6.
go back to reference Ponticelli C, Traversi L, Feliciani A, et al. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int. 2001;60:1948–54.CrossRefPubMed Ponticelli C, Traversi L, Feliciani A, et al. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int. 2001;60:1948–54.CrossRefPubMed
7.
go back to reference Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004 Jan;15(1):157–63.CrossRefPubMed Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004 Jan;15(1):157–63.CrossRefPubMed
8.
go back to reference Pratt LW. Tonsillectomy and Adenoidectomy: mortality and morbidity. Trans Am Acad Ophthalmol Otolaryngol. 1970;74:1146–54.PubMed Pratt LW. Tonsillectomy and Adenoidectomy: mortality and morbidity. Trans Am Acad Ophthalmol Otolaryngol. 1970;74:1146–54.PubMed
9.
go back to reference Windfuhr JP, Chen YS. Post-tonsillectomy and -adenoidectomy hemorrhage in nonselected patients. Ann Otol Rhinol Laryngol. 2003;112:63–70.CrossRefPubMed Windfuhr JP, Chen YS. Post-tonsillectomy and -adenoidectomy hemorrhage in nonselected patients. Ann Otol Rhinol Laryngol. 2003;112:63–70.CrossRefPubMed
10.
go back to reference Lowe D, van der Meulen J, et al. Tonsillectomy technique as a risk factor for postoperative haemorrhage. Lancet. 2004;364:697–702.CrossRefPubMed Lowe D, van der Meulen J, et al. Tonsillectomy technique as a risk factor for postoperative haemorrhage. Lancet. 2004;364:697–702.CrossRefPubMed
11.
go back to reference Walker P, Gillies D, et al. Post-tonsillectomy hemorrhage rates: are they technique-dependent? Otolaryngol Head Neck Surg. 2007;136(4 Suppl):S27–31.CrossRefPubMed Walker P, Gillies D, et al. Post-tonsillectomy hemorrhage rates: are they technique-dependent? Otolaryngol Head Neck Surg. 2007;136(4 Suppl):S27–31.CrossRefPubMed
12.
go back to reference Arnoldner C, Grasl MC, Thurnher D, et al. Surgical revision of hemorrhage in 8388 patients after cold-steel adenotonsillectomies. Wien Klin Wochenschr. 2008;120:336–42.CrossRefPubMed Arnoldner C, Grasl MC, Thurnher D, et al. Surgical revision of hemorrhage in 8388 patients after cold-steel adenotonsillectomies. Wien Klin Wochenschr. 2008;120:336–42.CrossRefPubMed
13.
go back to reference Hessén Söderman AC, Ericsson E, Hemlin C, et al. Reduced risk of primary postoperative hemorrhage after tonsil surgery in Sweden: results from the National Tonsil Surgery Register in Sweden covering more than 10 years and 54,696 operations. Laryngoscope. 2011;121:2322–6.CrossRefPubMed Hessén Söderman AC, Ericsson E, Hemlin C, et al. Reduced risk of primary postoperative hemorrhage after tonsil surgery in Sweden: results from the National Tonsil Surgery Register in Sweden covering more than 10 years and 54,696 operations. Laryngoscope. 2011;121:2322–6.CrossRefPubMed
14.
go back to reference Tomkinson A, Harrison W, Owens D, et al. Risk factors for postoperative hemorrhage following tonsillectomy. Laryngoscope. 2011;121:279–88.CrossRefPubMed Tomkinson A, Harrison W, Owens D, et al. Risk factors for postoperative hemorrhage following tonsillectomy. Laryngoscope. 2011;121:279–88.CrossRefPubMed
15.
go back to reference Kennoki T, Ishida H, Yamaguchi Y, et al. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation. Transplantation. 2009;88:935–41.CrossRefPubMed Kennoki T, Ishida H, Yamaguchi Y, et al. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation. Transplantation. 2009;88:935–41.CrossRefPubMed
16.
go back to reference Giannakakis K, Feriozzi S, Perez M, et al. Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy. J Am Soc Nephrol. 2007;18:3139–46.CrossRefPubMed Giannakakis K, Feriozzi S, Perez M, et al. Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy. J Am Soc Nephrol. 2007;18:3139–46.CrossRefPubMed
17.
go back to reference Kawamura T, Yoshimura M, Miyazaki Y, et al. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin a nephropathy. Nephrol Dial Transplant. 2014;29:1546–53.CrossRefPubMedPubMedCentral Kawamura T, Yoshimura M, Miyazaki Y, et al. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin a nephropathy. Nephrol Dial Transplant. 2014;29:1546–53.CrossRefPubMedPubMedCentral
18.
go back to reference Liu LL, Wang LN, Jiang Y, et al. Tonsillectomy for IgA nephropathy: a meta-analysis. Am J Kidney Dis. 2015;65:80–7.CrossRefPubMed Liu LL, Wang LN, Jiang Y, et al. Tonsillectomy for IgA nephropathy: a meta-analysis. Am J Kidney Dis. 2015;65:80–7.CrossRefPubMed
19.
go back to reference Katafuchi R, Kawamura T, Joh K, et al. Pathological sub-analysis of a multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy versus steroid pulse monotherapy in patients with immunoglobulin a nephropathy. Clin Exp Nephrol. 2016;20:244–52.CrossRefPubMed Katafuchi R, Kawamura T, Joh K, et al. Pathological sub-analysis of a multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy versus steroid pulse monotherapy in patients with immunoglobulin a nephropathy. Clin Exp Nephrol. 2016;20:244–52.CrossRefPubMed
20.
go back to reference Tsuchiya T, Ito S, Yamaguchi Y, et al. Tonsillectomy and steroid pulse therapy for recurrent IgA nephropathy in renal allograft. Clin Nephrol. 2010;73:68–71.CrossRefPubMed Tsuchiya T, Ito S, Yamaguchi Y, et al. Tonsillectomy and steroid pulse therapy for recurrent IgA nephropathy in renal allograft. Clin Nephrol. 2010;73:68–71.CrossRefPubMed
21.
go back to reference Ushigome H, Suzuki T, Fujiki M, et al. Efficacy of tonsillectomy for patients with recurrence of IgA nephropathy after kidney transplantation. Clin Transpl. 2009;23 Suppl 20:17–22.CrossRef Ushigome H, Suzuki T, Fujiki M, et al. Efficacy of tonsillectomy for patients with recurrence of IgA nephropathy after kidney transplantation. Clin Transpl. 2009;23 Suppl 20:17–22.CrossRef
22.
go back to reference Sato Y, Ishida H, Shimizu T, et al. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy. Transpl Immunol. 2014;30:12–7.CrossRefPubMed Sato Y, Ishida H, Shimizu T, et al. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy. Transpl Immunol. 2014;30:12–7.CrossRefPubMed
23.
go back to reference Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357:2562–75.CrossRefPubMed Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357:2562–75.CrossRefPubMed
24.
go back to reference Shihab FS, Waid TH, Conti DJ. Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF study. Transplantation. 2008;85(9):1261.CrossRefPubMed Shihab FS, Waid TH, Conti DJ. Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF study. Transplantation. 2008;85(9):1261.CrossRefPubMed
25.
go back to reference Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931–40.CrossRefPubMed Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931–40.CrossRefPubMed
26.
go back to reference Hricik DE, Formica RN, Nickerson P, et al. Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients. J Am Soc Nephrol. 2015;26:3114–22.CrossRefPubMedPubMedCentral Hricik DE, Formica RN, Nickerson P, et al. Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients. J Am Soc Nephrol. 2015;26:3114–22.CrossRefPubMedPubMedCentral
27.
go back to reference Budde K, Becker T, Arns W, et al. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet. 2011;377:837–47.CrossRefPubMed Budde K, Becker T, Arns W, et al. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet. 2011;377:837–47.CrossRefPubMed
28.
go back to reference Weir MR, Mulgaonkar S, Chan L, et al. Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled spare-the-nephron trial. Kidney Int. 2011;79:897–907.CrossRefPubMed Weir MR, Mulgaonkar S, Chan L, et al. Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled spare-the-nephron trial. Kidney Int. 2011;79:897–907.CrossRefPubMed
29.
go back to reference Lim WH, Eris J, Kanellis J, et al. A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients. Am J Transplant. 2014;14:2106–19.CrossRefPubMed Lim WH, Eris J, Kanellis J, et al. A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients. Am J Transplant. 2014;14:2106–19.CrossRefPubMed
30.
go back to reference Gallon L, Traitanon O2, Sustento-Reodica N, et al. Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus. Kidney Int. 2015;87:828–38.CrossRefPubMed Gallon L, Traitanon O2, Sustento-Reodica N, et al. Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus. Kidney Int. 2015;87:828–38.CrossRefPubMed
Metadata
Title
Successful treatment of recurrent immunoglobulin a nephropathy using steroid pulse therapy plus tonsillectomy 10 years after kidney transplantation: a case presentation
Authors
Haruki Katsumata
Izumi Yamamoto
Yo Komatsuzaki
Mayuko Kawabe
Yusuke Okabayashi
Takafumi Yamakawa
Ai Katsuma
Yasuyuki Nakada
Akimitsu Kobayashi
Yudo Tanno
Jun Miki
Hiroki Yamada
Ichiro Ohkido
Nobuo Tsuboi
Hiroyasu Yamamoto
Takashi Yokoo
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-0858-9

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.